wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33476874-2D353107-DBCC-49BB-847E-ACEF679D9D06
Q33476874-2D353107-DBCC-49BB-847E-ACEF679D9D06
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33476874-2D353107-DBCC-49BB-847E-ACEF679D9D06
ERK2, but not ERK1, mediates acquired and "de novo" resistance to imatinib mesylate: implication for CML therapy
P2860
Q33476874-2D353107-DBCC-49BB-847E-ACEF679D9D06
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33476874-2D353107-DBCC-49BB-847E-ACEF679D9D06
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5059db253d3425b500b46495fc1c5f0732e221e8
P2860
The development of imatinib as a therapeutic agent for chronic myeloid leukemia.